Possible interconnection between irational doping, veterinary medication, and pathomorphological changes in the iliac artery segment in population of cyclists who have infected and recovered from Covid-19 disease
Main Article Content
Abstract
Introduction: Doping which includes veterinary drugs as irrational human medicine after the infection with COVID 19 still leaves the field open from the aspect of vascular surgery and angiology of the iliac segment. Reflection of the effect of the COVID 19 virus on the sports performance of athletes in various sports after the corona virus is still present. Some athletes have had a hard time individually coping with the clinical consequences after a long illness of the COVID 19 virus. Even though covert doping is part of the everyday life of an elite athlete, it still remains an unresolved topic in the form of a solution for post-COVID 19 symptoms or switching to or taking some other masked substances that are impossible to detect in the blood, as well as a potential reflection on the morphological changes of the arteries. Although consequences of the corona virus for the cardiorespiratory system have been reported, a question arises as to the connection between the development of iliac syndrome and pathomorphological arterial iliac changes in athletes with suspicion of potential correlation with underground doping substances of pharmacologically untested origin in the Balkan population. Widespread global COVID 19 pandemic and the isolation factor have forced numerous athletes to switch their normal training routine and protocols to alternatives such as cycling with or without abusing illegal substance. Increased intima-media thickness, the first structural change detected in atherosclerosis, is an important surrogate marker in atherosclerosis can be connected with high intensity endurance cyclists, running and triathlon competitive athletes affecting their poor performance status and professional doping levels. In some cases, amateur and recreational athletes are also affected especially if they were exposed to COVID 19 infection and doping. Goals: The primary focus of the present study is to determine the initial progression of the disease during and after the COVID 19 pandemic, starting from morphological changes and obstructive arteriopathy of the external iliac artery on account of measuring intima media thickness and the possibility of outset of kinking and obstructive arterial disease of the external iliac artery after 3 years. The secondary focus of the study is to examine the influence of doping on the pathomorphological changes of the external iliac artery during 3 years of research.
Subjects and Methods: two groups of were observed (recreational and amateur cyclist). In total 63 selected subjects in the demographic area of former Yugoslavia without cardiovascular disease were observed during the January 2021 and January 2024 period (3 years).
Results: Changes in intima-media thickness of iliac artery from baseline 3 years were observed between the standard exercise amateur group and recreational control group. However, intensity exercise under 9000km per year were no significant developing progression of intima-media thickness of iliac artery during 3 years in recreational control group, but minimal progression of intima-media thickness of iliac artery were significant in amateur cycling group due to the potential effect of doping.
Conclusion: The application of doping itself is indisputable, but the missing link that would confirm this claim is scientifically limited. We cannot confirm with certainty what is the trigger for the progression of pathomorphological changes and whether the consequences of overcoming the COVID 19 infection or doping. But there are many scientific facts and studies that confirm the connection between progressive atherosclerosis and illegal underground doping substances of pharmacologically untested origin. The consequences may result with a tendency for a futuristic vascular invasive patch or bypass surgical treatment.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Solakovic S, Vrcic M, Pavlovic R et al. Irational Abuse of Anabolic Steroids Stacking with Aro-matase Inhibitors Increase Carotid Intima-Me-dia Thickness (CIMT) and Lowerining High Den¬sity Lipoprotein (HDL) levels Causing High Risk Factors for Cardiovascular Disease and Potential Steatohepatitis in Young Recreational Bodybuilders Age 17-30 (pilot study). International journal of Exercise Physiology. 2019;8 (3.1): 197-207.
3. Solakovic S, Vrcic M, Solakovic N, Pavlovic R. Irrational Abuse of Testosterone and Mass Supplements by Recreational Bodybuilders with “Adonis Complex” Leads to Potential Cardiovascular Diseases and Psychophysical Disorders. International Journal of Sports Science. 2016; (6): 230-236. doi:10.5923/j.sports.20160606.05
4. Solakovic S, Vrcic M, Pavlovic R, et al. Potential Cardiovascular Side Effects Of Trenbolone Acetate Steroid Stacking In Young Section A-Research paper Recreational Bodybuilders Compared With Another Potential Cardiovascular Side Effects Of Anabolic Steroids And What Is Thoroughly Hiding Behind Trenbolone Acetate Road Rage Myth? European Chemical Bulletin. 2022; 11(11):64-72. DOI:10.31838/ecb/2022.11.11.007
5. Solakovic S, Vrcic M, Pavlovic R, Solakovic E. Vascular Rehabilitation Benefits of Tribulus Terrestris (TT) Taurine and High Dose Alpha Lipoic Acid (ALA) Supplementation with Interval Walking Training Program after Surgical Vascular Bypass Treatment (Pilot Study). International Journal of Kinesiology and Sports Science. 2019; 7(3):22-33. doi.org/10.7575/aiac.ijkss.v.7n.3p.22
6. Feugier P, Chevalier JM. Endofibrosis of the iliac arteries: an underestimated problem. Acta Chir Belg. 2004;104(6):635-40. doi: 10.1080/00015458. 2004.11679635
7. Aubel O et al Doping risk and career turning points in male elite road cycling (2005-2016). J Sci Med Sport. 2018 Mar 14. pii: S1440-2440(18)30070 -7. doi: 10.1016/j.jsams.2018.03.003.
8. Chevalier JM. Pathologie vasculaire du cyclistes. Encyclopedie Medico Chirurgicale 1997; A10eA11:675.
9. Bender MH, Schep G, de Vries WR, Hoogeveen AR, Wijn PF. Sports-related flow limitations in the iliac arteries in endurance athletes: aetiology, diagnosis, treatment and future developments. Sports Med. 2004;34(7):427-42. doi: 10.2165/0000 7256-200434070-00002.
10. Kral CA, Han DC, Edwards WD, Spittell PC, Tazelaar HD, Cherry KJ Jr. Obstructive external iliac arteriopathy in avid bicyclists: new and variable histopathologic features in four women. J Vasc Surg. 2002;36(3):565-70. doi: 10.1067/mva.2002.126558.
11. Chevalier JM, Enon B, Wälder J, et al. Endofibrosis of the external iliac artery in bicycle racers: an unrecognized pathological state. Ann. Vase. Surg. 1986; 1:297-303.
12. Del Gallo G, Plissonnier D, Planet M, et al. Dissecting aneurysm of the external iliac artery: an unusual course of endofibrosis in an athlete. J. Mai. Vase. 1996; 21:95-7.
13. Desvaux B, Abraham P, Colin D, Leftherittis G, Saumet JL. Ankle to arm index following maximal exercise in normal subjects and athletes. Med. Sa. Sports Exerc. 1996; 28:836-9.
14. Fernández-García B, Alvarez Fernández J, Vega García F, Terrados N, Rodríguez-Alonso M, Alvarez Rodríguez E, Rodríguez Olay JJ, Llaneza Coso JM, Carreño Morrondo JA, Angeles Menendez-Herrero M, María Gutierrez Julián J. Diagnosing external iliac endofibrosis by postexercise ankle to arm index in cyclists. Med Sci Sports Exerc. 2002;34(2):222-7. doi: 10.1097/0000 5768-200202000-00007.
15. Abnihiim P, Bouyé P, Quéré et al. Past. present. and future of arterial endofibrosis in athletes: a point of view. Strt. Med. 2004; 34(7):419-25.
16. Giannoukas AD, Berczi V, Anoop U, Cleveland TJ, Beard JD, Gaines PA. Endofibrosis of iliac arteries in high-performance athletes: diagnostic approach and minimally invasive endovascular treatment. Cardiovasc Intervent Radiol. 2006;29(5): 866-9.doi: 10.1007/s00270-004-0202-6.
17. Manning J. Exertional thigh pain in a cyclist. AMSSM 2010 Poster Presentation. 2007.
18. Maree AO, Ashequl Islam M, Snuderl M, Lamuraglia GM, Stone JR, Olmsted K, Rosenfield KA, Jaff MR. External iliac artery endofibrosis in an amateur runner: hemodynamic, angiographic, histopathological evaluation and percutaneous revascularization. Vasc Med. 2007;12(3):203-6. doi: 10.1177/1358863X07080844.
19. Schep G, Bender MH, Kaandorp D, Hammacher E, de Vries WR. Flow limitations in the iliac arteries in endurance athletes. Current knowledge and directions for the future. Int J Sports Med. 1999 Oct;20(7):421-8. doi: 10.1055/s-1999-8826.
20. Vink A, Bender MH, Schep G, van Wichen DF, de Weger RA, Pasterkamp G, Moll FL. Histopathological comparison between endofibrosis of the high-performance cyclist and atherosclerosis in the external iliac artery. J Vasc Surg. 2008; 48(6):1458-63. doi: 10.1016/j.jvs.2008.07.057.
21. Wijesinghe LD, Coughlin PA, Robertson I, Kessel D, Kent PJ, Kester RC. Cyclist's iliac syndrome: temporary relief by balloon angioplasty. Br J Sports Med. 2001 Feb;35(1):70-1. doi: 10.1136 /bjsm.35.1.70
22. Monti M, Jaeger M, Guisan Y, Payot M, Mazzoni S. Diagnosis of peripheral arterial insufficiency in the amateur athlete with claudication and the detection of ‘‘the isolated iliac artery stenosis syndrome in young bicyclists with no risk factors’’ with the Doppler and rolling carpet tests. Rev Med Suisse Romande 1984;104(10):823e30.
23. Schep G, Kaandorp DW, Bender MH, Van Engeland S, Weerdenburg H, Titulaer BM, Wijn PF. Excessive length of iliac arteries in athletes with flow limitations measured by magnetic resonance angiography. Med Sci Sports Exerc. 2002; 34(3):38 5-93. doi: 10.1097/00005768-200203000-00001.
24. Mathews J. Acute Aortic Dissection in a Young Healthy Athlete with Androgenic Anabolic Steroid Use: A Case Report from Qatar. J Cardiovasc Dis Diagn. 2014; 2:152. doi:10.4172/2329-9517.1000152.
25. Heuberger JAAC, Rotmans J, et al. Effects of erythropoietin on cycling performance of well-trained cyclists: a double-blind, randomized, placebo-controlled trial. Lancet Haematol. 2017; 4(8):374-386.
26. Heuberger JA, Cohen Tervaert JM et al Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit. Br J Clin Pharmacol. 2013; 75 (6):1406-1412.
27. Kuipers H, et al. Putative effects of doping in cycling. Ned Tijdschr Geneeskd. 2006; 2; 150 (48):2643-2645.
28. Al-Saadi EAKD, Abdulnabi MA. Hematological changes associated with COVID-19 infection. J. Clin. Lab. Anal. 2022; 6. e24064. 10.1002/jcla.24064.
29. Brundyn JL, Gillan J, Singh I. Hematologic abnormalities associated with post-acute COVID-19 sequelae or “long-COVID”-a systematic review. Int. J. Bio. Lab. Sci. 2022; 11 (1): 23–42.
30. Wilson TD, Revesz E, Podbielski FJ, Blecha MJ. External iliac artery dissection secondary to endofibrosis in a cyclist. J Vasc Surg. 2010; 52(1):219–21.
31. Bender MH, Schep G, Bouts SW, Backx FJ, Moll FL. Endurance athletes with intermittent claudication caused by iliac artery stenosis treated by endarterectomy with vein patch--short- and mid-term results. Eur J Vasc Endovasc Surg. 2012; 43(4):472-7. doi: 10.1016/j.ejvs.2012.01.004.
32. Peach G, Schep G, Palfreeman R, Beard JD, Thompson MM, Hinchliffe RJ. Endofibrosis and kinking of the iliac arteries in athletes: a systematic review. Eur J Vasc Endovasc Surg. 2012;43(2):208-17. doi: 10.1016/j.ejvs.2011.11.019.
33. Basst D. Howley et al: Limitation Factors for Maximum Oxigen Uptake and determination of endurance Performance. Med.Sci.Sports.Exerc. (1999).70-83.
34. Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001; 89: 763–771.
35. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA. 2001; 285(19):2481-5. doi: 10.1001/jama.285.19.2481.
36. Ferrer M, Encabo A, Marín J, Balfagón G. Treatment with the anabolic steroid, nandrolone, reduces vasoconstrictor responses in rabbit arteries. Eur J Pharmacol. 1994;258(1-2):103-10. doi: 10.1016/0014-2999(94)90062-0.
37. Lopez JF, Magne JL, Champetier J. The femoral artery and flexion of the hip joint. Surg Radiol Anat. 1989;11(4):275-81. doi: 10.1007/BF02 098696.
38. Rousselet MC.Saint Andre JP.L’Hoste PH.Enon B.MegretA.Chevalier JM. Stenotic intima media thickness of the external iliac artery in competitive cyclists. Hum Pathol. 1990; 21: 524 – 529.
39. Heuberger. JAC, Cohen JM, TSchepers FML, Vliegenthart ADB, Rotmans JI, Daniels JMA, Burggraaf J, Cohen AF. Erythropoietin doping in cycling: Lack of evidence for efficacy and a negative risk-benefit. British Journal of Clinical Pharmacology. 2012; DOI: 10.1111/bcp.12034
40. Böning D, Maassen N, Pries A. The hematocrit paradox--how does blood doping really work? Int J Sports Med. 2011;32(4):242-6. doi: 10.1055/s-0030-1255063.
41. Padilla S, Mujika I, Orbañanos J, Angulo F. Exercise intensity during competition time trials in professional road cycling. Med Sci Sports Exerc. 2000;32(4):850-6. doi: 10.1097/00005768-200004 000-00019.
42. Lundby C. Hellsten Y. Jensen MB. Munch AS. Pilegaard H. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle. J Appl Physiol 2008; 104: 1154–60
43. Jules A AC, Heuberger, et al. Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk–benefit. Br J Clin Pharmacol. 2012 ;75:(6 ):1406–142.
44. Scmidt W, Bierbaum, et al. How is valid determination of Hematocrit Values to detect Blood Manipulation. Int.J.Sports Med. 2000; (21):133-138.
45. Jonas AP et al. Substance abuse2 .Clin.Sport Medd. 11.379-401.
46. Delbeke FT, et al. Doping in Cyclism: Results of unannounced controls in Flanders. (1987-1994). Int J. Sports Med 1996; (17):434-438.
47. Khaira HS, Awad RW, Aluwihare N, Shearman CP. External iliac artery stenosis in a young body builder. Eur J Vasc Endovasc Surg. 1996;11(4):499-501. doi:10.1016/s1078-5884(96)80189-4.
48. Solakovic S, Vrcic M, Pavlovic R, et al. HDL Level In Amateur Bodybuilders Who Misuse The Combination Of Testosterone Products And Anabolic Steroids In Bosnia And Herzegovina. Slovak Journal of Sport Science. 2016; 1 (1): 2-8.
49. Solakovic S, Vrcic M, Pavlovic R, Solakovic E. Vascular Rehabilitation Benefits of Tribulus Terrestris (TT). Taurine and High Dose Alpha Lipoic Acid (ALA) Supplementation with Interval Walking Training Program after Surgical Vascular Bypass Treatment (Pilot Study). International Journal of Kinesiology and Sports Science. 2019; 7(3):22-33. doi.org/10.7575/aiac.ijkss.v.7n.3p.22
50. Solaković S, Spahović H, PavloviC R, Jogunčić A, Solaković N, Vrcić M, Hajrulahović, F. Connection of Low Serum Testosterone Levels in Cardiovascular Disease in Metabolic Syndrome Patients with Diagnosis of Critic Iliac Artery Stenosis (TASC II A and B) and Can Exercise Improve those Levels and Primary Potency of Revascularization after Surgical and Endovascular Treatment? (Pilot Study). Saudi J Med. 2023; 8(1): 8-17. DOI: 10.36348/sjm.2023.v08i01.002
51. Solakovic S, Pavlovic R, Vrcic M. Does Hyperbaric Oxygen Therapy (HBOT) Combined with Irrational Abuse of Stacking Anabolic Steroids by Recreational Bodybuilder Supporting Anaerobes Strength Improvement and Offer Cardiovascular Protection? (Pilot study) Journal of Sports Medicine and Pain Management. 2020; 1: 001-007.
52. Solakovic S, Vrcic M, Pavlovic R, et al. Whether exercises and testosterone replacement therapy support a treatment for cardiovascular and atherosclerotic patients with iliac artery stenosis and low total testosterone and high-density lipoprotein cholesterol after endovascular procedure? Zaporozhye Medical Journal. 2023; 25 (2):101-108. doi.org/10.14739/2310-1210.2023.2.268513.
53. Solaković S, Vrcić M, Pavlović R. Benefits of physical activity on diabetic and non-diabetic patients in fontaine’s stage IIa of peripheral artery disease in Bosnia and Herzegovina. Journal of Physical Education Research. 2016;3 (2): 23-33.
54. Solaković S, Vrcić M, Pavlović R, Alagaić-Alimanović, R. Can The Irregular Acetylsalicylic Acid (Asa) Therapy Combined With Interval Training Exercise Program Increase The Claudication Distance In Diabetic And Non-Diabetic Patients With Femoro-Popliteal Stenosis Age Over 55. European Journal of Physical Education and Sport Science. 2017; 3 (2): │ 2017.
55. Solakovic S, et al. Therapeutic Measures from Cardiovascular Damage using Statins. Acetylsalicylic Acid during the Abuse of Irrational Cycles of Anabolic Steroids in Bodybuilder Who Were Infected with the COVID-19. Medical Research Archives. 2024; 12, 2
56. Solakovic S, Vrcic M, Pavlovic R, et al. Can Self-controlled Stationary Bicycle Moderate Intensity Training Increase Claudication Distance in Patients with Fontains Stage IIa without the Effects of Expansion on Infrarenal Abdominal Aortic Aneurysm (IAAA) Diameter without Iliac Artery Dilatation (IAD) and Iliac Artery Aneurysms (IAA)? International journal of Exercise Physiology. 2019; 8 (3.1): 180-190.
57. Park JW, Lyu J, Ji TH, Yu SN, Jeon MH. Right Common Iliac Artery Occlusion in a Patient with Severe COVID-19. Infect Chemother. 2023;55(2): 295-298. doi: 10.3947/ic.2021.0074.
58. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538. doi: 10.1007/s0039 2-020-01626-9.
59. Lechuga GC, Morel CM, De Simone SG. Hematological alterations associated with long COVID-19. Front Physiol. 2023; 24;14:1203472. doi: 10.3389/fphys.2023.1203472.
60. Anai M, Akaike K, Iwagoe H, Akasaka T, Higuchi T, Miyazaki A, et al. Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia. Respir. Investig. 2021; 59. 187–193. Doi: 10.1016/J.RESINV.2020.10.009.
61. Alfadda AA, Rafiullah M, Alkhowaiter M, Alotaibi N, Alzahrani M, Binkhamis K, et al. Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation. Front. Med. (Lausanne) 2022; doi: 9.1067082. 10.3389/fmed.2022.1067082.
62. Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front Endocrinol (Lausanne). 2022; 19;13:1059473. doi: 10.3389/fendo.2022.1059473.
63. Cavezzi A, Troiani E, Corrao S. COVID-19: Hemoglobin. iron. and hypoxia beyond inflammation. A narrative review. Clin. Pract. 2020; 10. 1271. Doi.10.4081/cp.2020.1271.
64. Fan BE, Wong SW, Sum CLL, Lim GH, Leung BP, Tan CW, et al. Hypercoagulability, endotheliopathy. and inflammation approximating 1 year after recovery: Assessing the long‐term outcomes in COVID‐19 patients. Am. J. Hematol. 2022; 97. 915–923. Doi.10.1002/ajh.26575